Diabetic Foot Ulcers
Diabetic foot ulcer market burden, limb preservation, vascular risk, recurrence, and care-delivery visuals.
Series focus
Diabetic foot ulcer market burden, limb preservation, vascular risk, recurrence, and care-delivery visuals.
Reports in this series

A high-risk limb-preservation market shaped by chronic burden, slow healing, recurrence, infection, vascular disease, and coordinated care.

How early wound assessment, offloading, vascular checks, and home support can change the diabetic foot pathway.

How symptom recognition, vascular testing, referral timing, and surveillance change the peripheral artery disease pathway.

Why a foot ulcer can become a limb-threatening episode when neuropathy, ischemia, infection, offloading, wound care, and follow-up all have to align.

A high-risk diabetes complication creates clinical and economic burden when neuropathy, PAD, infection, and follow-up gaps delay healing.

Diabetes prevalence, ulcer recurrence, limb preservation, wound-care innovation, vascular coordination, and value pressure reinforce DFU market demand.
